HUTCHMED (China) Limited (HKG:0013)
25.20
-0.55 (-2.14%)
Mar 3, 2025, 4:08 PM HKT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
2.42M HKD
Profits / Employee
-166.35K HKD
Market Cap
22.25B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
JD Health International | 3,118 |
Hansoh Pharmaceutical Group Company | 9,123 |
WuXi Biologics | 12,740 |
Alibaba Health Information Technology | 1,435 |
Innovent Biologics | 4,872 |
Akeso | 2,778 |
Sinopharm Group | 115,959 |
HUTCHMED (China) News
- 11 days ago - HUTCHMED (China) Ltd (HCM) Announces Upcoming Financial Results Release - GuruFocus
- 12 days ago - HUTCHMED to Announce 2024 Final Results - GlobeNewsWire
- 4 weeks ago - Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade) - Seeking Alpha
- 6 weeks ago - HUTCHMED (China) Ltd (HCM) Shares Gap Down to $13.87 on Jan 15 - GuruFocus
- 6 weeks ago - Hutchmed (HCM) Shares Drop Over 5.7% Amid Delayed Approvals - GuruFocus
- 6 weeks ago - HUTCHMED (China) Ltd (HCM) Gains Full Approval for ORPATHYS® in China - GuruFocus
- 6 weeks ago - HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC - GlobeNewsWire
- 2 months ago - Chinese regulators accept NDA for Orpathys/Tagrisso combo - Seeking Alpha